Načítá se...
Biological intratumoral therapy for the high-grade glioma part I: intratumoral delivery and immunotoxins
Management of high-grade gliomas remains a complex challenge. Standard of care consists of microsurgical resection, chemotherapy and radiation, but despite these aggressive multimodality therapies the overall prognosis remains poor. A major focus of ongoing translational research studies is to devel...
Uloženo v:
| Vydáno v: | CNS Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6880302/ https://ncbi.nlm.nih.gov/pubmed/31747788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2019-0001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|